Orifarm Group

adminMarch 31, 2021
0 2

Takeda Completes Sale of Select OTC and Non-Core Assets to Orifarm

OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
Read More »
adminSeptember 8, 2020
17

Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD

Osaka, Japan: Divestiture strategy on track Portfolio includes prescription products in Takeda’s Cardiovascular/Metabolic and Anti-inflammatory therapeutic areas along with Calcium Takeda…
Read More »